Effect of obesity on perioperative outcomes following lung cancer surgery: a systematic review and meta-analysis

肥胖对肺癌手术围手术期结局的影响:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: This meta-analysis systematically evaluated the impact of obesity on perioperative outcomes in patients undergoing lung cancer surgery to provide robust evidence for clinical decision-making and patient management. METHODS: A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Comprehensive searches were performed across PubMed, Embase, The Cochrane Library, Web of Science, and Medline. A random-effects model was employed, and the meta-analysis was conducted using Stata software (version 16.0). RESULTS: Eighteen studies comprising 88,413 participants were included in the meta-analysis. Postoperative mortality was significantly lower in the obese group (odds ratio [OR]: 0.73; 95% confidence interval [CI]: 0.59-0.90; P = 0.003). Statistically non-significant differences were observed between the two groups regarding postoperative complications (OR: 1.14; 95% CI: 0.71-1.84; P = 0.582), pulmonary complications (OR: 1.21; 95% CI: 0.57-2.58; P = 0.621), cardiovascular complications (OR: 1.54; 95% CI: 0.86-2.76, P = 0.150), and the total hospital stays (standardized mean difference [SMD]: -0.00; 95% CI: -0.17 to 0.17; P = 0.995). However, operation time was significantly longer in the obese group (SMD: 0.18; 95% CI: 0.11-0.26; P < 0.001). CONCLUSION: The obesity paradox may exist in patients undergoing lung cancer surgery. Although obesity is associated with longer operation duration, it neither increases the risk of complications nor prolongs hospital stays and is generally linked to reduced postoperative mortality. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD42025648330, identifier CRD42025648330.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。